Delivery Order SPE2DB20D1100-SPE2DB24FC6M1

Award Date 7/9/24
Potential Completion Date 7/30/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.84 firm fixed-price contract is for the delivery of NPLATE 125 MCG VIALS, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,788.75 firm fixed-price delivery order is for NPLATE 125 MCG VIALS, a critical pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.52 delivery order contract is for the supply of NPLATE 125 MCG VIALS, a specialized pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 28, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $2,302.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NPLATE 125 MCG vials, a specialty medication, to support military healthcare programs. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of NPLATE 125 MCG VIALS. The contract is a Firm Fixed Price Delivery Order valued at $2,225.49 with a completion date of July 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,225.49, is a delivery order for the supply of 4564881091 NPLATE 125 MCG VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of July 3, 2024. This contract award is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $3,837.40, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of NPLATE 125 MCG VIALS, a pharmaceutical product. The contract has a firm fixed price structure and an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,225.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NPLATE 125 MCG VIALS, a critical medical product, with a completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $2,225.49 firm fixed price delivery order is to provide NPLATE 125 MCG VIALS, a pharmaceutical product, to DLA Troop Support Medical facilities. The contract has a completion date of January 30, 2024 and was awarded on January 8, 2024. This award is not associated with a set-aside program....
This federal contract award, with a value of $4,450.98, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 125 mcg vials of the drug Nplate, with a performance period through November 14, 2024. The contract type is a Delivery Order with Firm Fixed Pricing. This contract award is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC6M1
    Delivery Order

The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,450.98 firm fixed-price delivery order is for the supply of NPLATE 125 MCG VIALS, a specialty pharmaceutical product. This award is associated with a broader Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen's federal contract portfolio demonstrates its significant role in supplying essential medical commodities, including specialty medications, generic drugs, and medical devices, to various government agencies and healthcare programs.

Generated 5/17/25, 9:58 AM